ZINC STEARATE†

Chemical Identification
Chemical Identification
CAS # 557-05-1
Formula

Zn(C₁₈H₃₅O₂)₂

Synonyms

dibasic zinc stearate; zinc salt of stearic acid; zinc distearate

Physical Properties
Physical Properties
Physical description Soft, white powder with a slight, characteristic odor.
Boiling point Molecular weight 632.4
Freezing point/melting point 266°F Vapor pressure 0 mmHg (approx)
Flash point 530°F (open cup) Vapor density
Specific gravity 1.10 Ionization potential
Lower explosive limit (LEL) Upper explosive limit (UEL)
NFPA health rating 1 NFPA fire rating 2
NFPA reactivity rating 0 NFPA special instruction
Vapor hazard ratio (VHR)
Historical exceedance percentage
Target organs
Monitoring Methods Used by OSHA
Monitoring Methods Used by OSHA
Analyte code (IMIS no.) 2616 (total); request using analyte code 9135 Z104 (resp); request using analyte code 9130
Sampling group
Sampler/Sampling media Tared low-ash 37 mm PVC filter, 5 microns [SLTC108] Tared low-ash 37 mm PVC filter, 5 microns, preceded by 10 mm nylon Dorr-Oliver cyclone for respirable samples. [SLTC108]
Sampling time*

240-480 min

240-480 min

Sampling volume (TWA)*

960 L

816 L

Sampling flow rate (TWA)*

2 L/min

1.7 L/min ±5%

Sampling volume (STEL/Peak/C)*
Sampling flow rate (STEL/Peak/C)*
Analytical method instruments Gravimetric Gravimetric
Method reference OSHA PV2121 (partially validated) OSHA PV2121 (partially validated)
Notes

Samples collected for this compound are first analyzed gravimetrically. If the gravimetric result of a sample yields a concentration below the permissible exposure limit (PEL), the SLTC will report the calculated air concentration for the requested compound solely from the gravimetric result, qualified as less than or equal to the gravimetric result; no further work on the sample will be performed. If the gravimetric result indicates an air concentration greater than the PEL, the sample will proceed for elemental analysis. Results will be reported from the elemental analysis for the element only; the stated identity of the actual sample contents is based on the assumption that the material sampled is as identified by the compliance officer using available documentation of materials and processes. An elemental result provided may be converted to the desired compound by multiplying the result by the appropriate stoichiometric factor.

A 91B report specific to the compound (including the stoichiometric conversion) may by be provided upon request by contacting the laboratory. The stoichiometric factor for zinc stearate from zinc is 9.670. The physical form of a sample (dust, mist, or fume) is identified by the compliance officer using available documentation of materials and processes.

Samples collected for this compound are first analyzed gravimetrically. If the gravimetric result of a sample yields a concentration below the permissible exposure limit (PEL), the SLTC will report the calculated air concentration for the requested compound solely from the gravimetric result, qualified as less than or equal to the gravimetric result; no further work on the sample will be performed. If the gravimetric result indicates an air concentration greater than the PEL, the sample will proceed for elemental analysis. Results will be reported from the elemental analysis for the element only; the stated identity of the actual sample contents is based on the assumption that the material sampled is as identified by the compliance officer using available documentation of materials and processes. An elemental result provided may be converted to the desired compound by multiplying the result by the appropriate stoichiometric factor.

A 91B report specific to the compound (including the stoichiometric conversion) may by be provided upon request by contacting the laboratory. The stoichiometric factor for zinc stearate from zinc is 9.670. The standard applies to the Respirable Fraction.

Special requirements

FOR TOTAL DUST SAMPLES, DO NOT USE A CYCLONE!!

Samples must be collected with a Dorr-Oliver cyclone.

* All sampling instructions above are recommended guidelines for OSHA Compliance Safety and Health Officers (CSHOs), please see the corresponding OSHA method reference for complete details.

Wipe Method
Wipe Method
Sampler/Sampling media
Bulk Method
Bulk Method
On-Site Screening Techniques
On-Site Screening Techniques
Device
Model/Type
Sampling information
(see manufacturer instructions)
Exposure Limits
Exposure Limits
OSHA PEL
8-hour TWA
(ST) STEL
(C) Ceiling
Peak
NIOSH REL
Up to 10-hour TWA
(ST) STEL
(C) Ceiling
ACGIH TLV©
8-hour TWA
(ST) STEL
(C) Ceiling
CAL/OSHA PEL
8-hour TWA
(ST) STEL
(C) Ceiling
Peak
PEL-TWA

15 mg/m³ (total dust), 5 mg/m³ (respirable fraction)

REL-TWA

10 mg/m³ (total), 5 mg/m³ (resp)

TLV-TWA

10 mg/m³ (inhalable particulate matter), 3 mg/m³ (respirable particulate matter) [2016]

PEL-TWA

10 mg/m³

PEL-STEL REL-STEL TLV-STEL PEL-STEL
PEL-C REL-C TLV-C PEL-C
Skin notation

N

Skin notation

N

Skin notation

N

Skin notation

N

Notes:

See 29 CFR 1910.1000 Table Z-1.

Notes: Notes:

Does not include stearates of toxic metals.

Notes:
Health factors:  See NIH-NLM PubChem. IDLH
Carcinogenic classifications: TLV-A4 Notes:
AIHA emergency response planning guidelines - ERPG-1/ERPG-2/ERPG-3:
Additional Resources and Literature References
Additional Resources and Literature References

NOAA: CAMEO Chemicals - Zinc stearate

NIOSH: Pocket Guide to Chemical Hazards - Zinc stearate

Literature References

  • ACGIH: Documentation of the Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) - Stearates(J) [57-11-4; 557-04-0; 557-05-1; 822-16-2]. See annual publication for most recent information.
  • Kilpikari, I.: Occupational contact dermatitis among rubber workers. Contact Dermatitis 8(6): 359-362, 1982.
  • Shabaline, L.P. and Spiridonova, V.S.: Toxicity and character of the effect of some zinc compounds. J. Hyg. Epidemiol. Microbiol. Immunol. 32(4): 397-405, 1988.
  • Ueda, A., Harada, K., Ueda, T. and Nomura, S.: Experimental study on the pathological changes in lung tissue caused by zinc stearate dust. Ind. Health 22(4): 243-253, 1984.

Last Updated Date : 01/14/2021